|
|
 |
|
Viewing report
|
|
|
|
The Pharmaceutical Industry Paradox: A Strategic Analysis Of The Countertrends Of Consolidation And Fragmentation
Business Insights, May 2002
The pharmaceutical industry currently represents a huge paradox. Whilst the pursuit of critical mass has driven consolidation and brought about the creation of mega-companies such as Pharmacia, GlaxoSmithKline and Pfizer, the industry as a whole and its markets remain highly fragmented. Similarly, consolidated companies have missed opportunities to re-engineer their processes, build greater brand effectiveness and, in fact, remain fragmented internally. The new report provides critical insights into the marketing and R&D implications of these key industry shifts. The report utilises an extensive survey of industry executives to pinpoint the strategic implications for industry players, providing the key data and analysis of strategies adopted by leading companies seeking to optimise both their current position and future prospects.
Customers who bought this item also bought
Indian Pharmaceutical Industry: Issues and Opportunities
Otsuka Pharmaceutical Co Deals Briefing
Pharmaceutical Outsourcing Strategies: Market Expansion, Offshoring and Strategic Management in the CRO and CMO Marketplace
The Pharmaceutical Licensing Outlook: A Strategic Guide To Effective Deal-Making And Profitable Partnerships
Teva Pharmaceutical Industries Ltd Deals Briefing
Takeda Pharmaceutical Co Ltd Deals Briefing
Corporate Branding on the Internet: A Strategic Guide for the Pharmaceutical Industry
Chinese Pharmaceutical Industry: Strategies, Trends and Opportunities
|
|
|
|
